Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906-Reference-Cited by-同舟云学术

Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906

Published:2011-02-25 Issue:4 Volume:57 Page:569-577
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Bowman W. Paul,Larsen Eric L.,Devidas Meenakshi,Linda Stephen B.,Blach Laurie,Carroll Andrew J.,Carroll William L.,Pullen D. Jeanette,Shuster Jonathan,Willman Cheryl L.,Winick Naomi,Camitta Bruce M.,Hunger Stephen P.,Borowitz Michael J.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22944/fullpdf

Reference44 articles.

1. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000);Silverman;Leukemia,2010

2. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia;Conter;Leukemia,2010

3. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report;Gaynon;Leukemia,2010

4. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000;Moricke;Leukemia,2010

5. Long-term results of St Jude Total Therapy Studies 11, 12 13A, 13B, and 14 for childhood acute lymphoblastic leukemia;Pui;Leukemia,2010

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study;Leukemia;2024-09-11

2. Comparison of augmented Berlin-Frankfurt-Münster (BFM) and BFM 2000 treatment protocols in children diagnosed with high-risk acute lymphoblastic leukemia;The European Research Journal;2024-09-04

3. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia;BMC Cancer;2024-08-29

4. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia;2024-07-18

5. STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B‐cell acute lymphoblastic leukaemia;British Journal of Haematology;2024-04-19